Bulk Drug Manufacturing in India
Challenges
- Meeting Demand: The burden of disease in the nation is high. Additionally, India inherited the burden of 17 per cent of maternal, perinatal, and childhood disorders as well as 8.2% of TB cases, 2.8% of TB cases, and 2.1% of HIV/AIDS cases. This opens up a sizable local market for pharmaceutical companies.
- The main problem facing the Indian pharmaceutical and API industries is meeting the rising demand from this sizable patient population.
- Exports: Pharmaceuticals have a sizable domestic and international market, but the business faces various obstacles to boosting production and export.
- They have to do with laws, both ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content
Already a Member? Login here
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material since 2018 of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Economic Development
- 1 Strengthening MSMEs: Challenges & Opportunities
- 2 Need for Reforms in Agricultural Marketing
- 3 Reforming the PDS for Better Nutrition
- 4 Monetary Policy & Poverty Alleviation: Challenges and Suggestions
- 5 Public Debt Management: Challenges and Way Forward
- 6 India's Agri-Subsidy and WTO Norms
- 7 FRBM Act: Fiscal Prudence vs. Contingent Compulsions
- 8 Regulation of Pharma Sector in India
- 9 Indian Discoms: Challenges and Suggestions
- 10 Critical Minerals for India
